New CAR T-Cell therapy targets tough leukemia in early trial
Disease control
Not yet recruiting
This study tests a new treatment called CCTx-001 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The therapy uses specially engineered immune cells to find and attack leukemia cells. The trial aims to find the best dose and ch…
Phase: PHASE1, PHASE2 • Sponsor: Advesya SAS • Aim: Disease control
Last updated May 18, 2026 12:07 UTC